Cargando…

Where Are We with RPE Replacement Therapy? A Translational Review from the Ophthalmologist Perspective

The retinal pigmented epithelium (RPE) plays a pivotal role in retinal homeostasis. It is therefore an interesting target to fill the unmet medical need of different retinal diseases, including age-related macular degeneration and Stargardt disease. RPE replacement therapy may use different cellular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raimondi, Raffaele, Zollet, Piero, De Rosa, Francesco Paolo, Tsoutsanis, Panagiotis, Stravalaci, Matteo, Paulis, Marianna, Inforzato, Antonio, Romano, Mario R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775975/ https://www.ncbi.nlm.nih.gov/pubmed/35054869 http://dx.doi.org/10.3390/ijms23020682

Ejemplares similares

Will AI Replace Ophthalmologists?
por: Korot, Edward, et al.
Publicado: (2020)

Erratum in: Will AI Replace Ophthalmologists?
Publicado: (2021)

Comparative analysis of large language models in the Royal College of Ophthalmologists fellowship exams
por: Raimondi, Raffaele, et al.
Publicado: (2023)

Eye care where there are no ophthalmologists: the Uganda experience
por: Magyezi, Joseph, et al.
Publicado: (2020)

Short-Term Outcomes After COVID-19-Related Treatment Interruption Among Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Bevacizumab
por: Allegrini, Davide, et al.
Publicado: (2021)

Neovascularization of engineered tissues for clinical translation: Where we are, where we should be?
por: Nazeer, Muhammad Anwaar, et al.
Publicado: (2021)

Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go
por: De Maria Marchiano, Ruggero, et al.
Publicado: (2021)

Evolving Indications of Transcatheter Aortic Valve Replacement—Where Are We Now, and Where Are We Going
por: Mesnier, Jules, et al.
Publicado: (2022)

Endogenous versus exogenous cell replacement for Parkinson’s disease: where are we at and where are we going?
por: Mourtzi, Theodora, et al.
Publicado: (2022)

Translational Research: Where Do We Go?
por: Kim, Nam Kug, et al.
Publicado: (2012)

Translational Health Research: where are we going?
por: da Silva, Gilberto Tadeu Reis, et al.
Publicado: (2023)

The Long Pentraxin PTX3 as a Link Between Innate Immunity, Tissue Remodeling, and Cancer
por: Doni, Andrea, et al.
Publicado: (2019)

The Long Pentraxin PTX3 as a New Biomarker and Pharmacological Target in Age-Related Macular Degeneration and Diabetic Retinopathy
por: Stravalaci, Matteo, et al.
Publicado: (2022)

An Australian Example of Translating Psychological Research into Practice and Policy: Where We are and Where We Need to Go
por: Werner-Seidler, Aliza, et al.
Publicado: (2016)

Hidradenitis Suppurativa: Where We Are and Where We Are Going
por: Scala, Emanuele, et al.
Publicado: (2021)

Interaction of C1q With Pentraxin 3 and IgM Revisited: Mutational Studies With Recombinant C1q Variants
por: Bally, Isabelle, et al.
Publicado: (2019)

The Role of Angiogenesis in Haemophilic Arthropathy: Where Do We Stand and Where Are We Going?
por: Agapidou, Alexandra, et al.
Publicado: (2016)

A novel quantitative analysis method for idiopathic epiretinal membrane
por: Allegrini, Davide, et al.
Publicado: (2021)

Minimally Invasive Joint Replacement Surgery: Where Are We Now?
por: Hong, Cheung Man
Publicado: (2017)

Genetics for the ophthalmologist
por: Sadagopan, Karthikeyan A., et al.
Publicado: (2012)

Burnout in ophthalmologists
por: Dudani, Ajay I
Publicado: (2018)

Role of an ophthalmologist after patient loses vision- are we doing enough?
por: Farooqui, Javed Hussain, et al.
Publicado: (2020)

All eyes on Coronavirus—What do we need to know as ophthalmologists
por: Khanna, Rohit C, et al.
Publicado: (2020)

Control of Complement Activation by the Long Pentraxin PTX3: Implications in Age-Related Macular Degeneration
por: Stravalaci, Matteo, et al.
Publicado: (2020)

Interstitial lung disease in systemic sclerosis: where do we stand?
por: Cappelli, Susanna, et al.
Publicado: (2015)

Translating tolerogenic therapies to the clinic – where do we stand?
por: Issa, Fadi, et al.
Publicado: (2012)

The peritumoral brain zone in glioblastoma: where we are and where we are going
por: Giambra, Martina, et al.
Publicado: (2022)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

Psychological impact of COVID-19 on ophthalmologists-in-training and practising ophthalmologists in India
por: Khanna, Rohit C, et al.
Publicado: (2020)

A narrative review of esophageal tissue engineering and replacement: where are we?
por: Model, Lynn, et al.
Publicado: (2021)

Selenium, Stroke, and Infection: A Threefold Relationship; Where Do We Stand and Where Do We Go?
por: Liampas, Andreas, et al.
Publicado: (2023)

Drugs for improving esophageal mucosa defense: where are we now and where are we going?
por: Savarino, Edoardo, et al.
Publicado: (2017)

Ophthalmologists beware of adenoviruses
por: Handor, Hanan, et al.
Publicado: (2014)

Early Ophthalmologists in Calcutta
por: Kirwan, E. O'G.
Publicado: (1938)

Empowering education for ophthalmologists
por: Stanca, T. Horia
Publicado: (2017)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

TSACO’s Third Anniversary: where we were, where we are, and where we’re going
por: Fabian, Timothy
Publicado: (2019)

Curcumin in Retinal Diseases: A Comprehensive Review from Bench to Bedside
por: Allegrini, Davide, et al.
Publicado: (2022)

Trans-Scleral Plugs Fixated FIL SSF IOL: A Review of the Literature and Comparison with Other Secondary IOL Implants
por: Raimondi, Raffaele, et al.
Publicado: (2023)

Translational perspectives to treat Epidermolysis bullosa—Where do we stand?
por: Prodinger, Christine, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kf3qincbljl6t7hj2fmanimfp6